Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses

Fig. 1

a and b: Network Diagrams, Available Evidence for Efficacy (Panel a) and Completion (Panel b). Totals of 16 RCTs (44,149 participants) and 14 RCTs (44,128 participants) were available for analyses of efficacy and completion, respectively. Treatment nodes are sized to reflect the proportion of patients studied on each intervention relative to the total number of patients studied. Edges joining different interventions are sized to reflect the proportion of studies informing each comparison (minimum 1 study). In comparisons where there is no line adjoining a pair of nodes, no eligible trials were identified. The online supplement provides a detailed summary of the numbers of studies in each connection as well as the total number of patients randomized to each intervention. Abbreviations. INH = isoniazid; RPT = rifapentine; RFMP = rifampin; PZA = pyrazinamide; trt = treatment; PL = placebo

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us